GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (FRA:BSX) » Definitions » Institutional Ownership

Boston Scientific (FRA:BSX) Institutional Ownership : 64.17% (As of May. 13, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Boston Scientific Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Boston Scientific's institutional ownership is 64.17%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Boston Scientific's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Boston Scientific's Float Percentage Of Total Shares Outstanding is 99.78%.


Boston Scientific Institutional Ownership Historical Data

The historical data trend for Boston Scientific's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Institutional Ownership Chart

Boston Scientific Historical Data

The historical data trend for Boston Scientific can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 65.38 65.18 64.85 65.78 62.91 63.00 64.07 63.95 63.76 64.17

Boston Scientific Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Boston Scientific (FRA:BSX) Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Boston Scientific (FRA:BSX) Headlines